ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time - Brown, Nancy J.; Kumar, Sandeep; Painter, Corrie A.; Vaughan, Douglas E. (Hypertension (Dallas, Tex. 1979), 2002)
Keywords: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive agents; Antihypertensive Agents - therapeutic use; Biological and medical sciences; Blood Glucose - drug effects; Blood Pressure - drug effects; Cardiovascular system; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide - therapeutic use; Hypertension - blood; Hypertension - drug therapy; Insulin - blood; Insulin Resistance - physiology; Losartan - therapeutic use; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Plasminogen Activator Inhibitor 1 - blood; Ramipril - therapeutic use; Receptor, Angiotensin, Type 1; Renin-Angiotensin System - drug effects; Sodium Chloride Symporter Inhibitors - therapeutic use; Tissue Plasminogen Activator - blood; Treatment Outcome; Morning; Cardiovascular disease; Ramipril; Glucose; Body mass index; Plasminogen activator inhibitor 1; Peptidyl-dipeptidase A; Losartan; Angiotensin II; angiotensin-converting enzyme; Human; Hypertension; Fasting; Enzyme; Enzyme inhibitor; Hydrochlorothiazide; Triglyceride; Insulin; plasminogen; Peptidases; Fibrin; Chemotherapy; Treatment; Biphenyl derivatives; renin; Risk factor; angiotensin; Hydrolases; Peptidyl-dipeptidases; Antihypertensive agent; Angiotensin antagonist; Thiazide; Comparative study; ACE inhibitor